Form #2 Form #2 Pre-intervention focus group guide with managers

Reduction of Infections Caused by KPC producing organisms Through Application of Recently Developed CDC/HICPAC Recommendations

Attachment D -- Pre-intervention focus group guide for managers

Pre-intervention focus groups with managers

OMB: 0935-0167

Document [docx]
Download: docx | pdf

Form Approved
OMB No. 0935-XXXX
Exp. Date XX/XX/20XX





Attachment D: Pre-intervention focus group guide for senior leaders

Thank you for meeting with us today and agreeing to participate in this research interview. As you are probably aware, your institution is preparing to implement a new set of guidelines for surveillance and control of KPC infections within _____ units. We are interested in learning about your perceptions of these new guidelines, their relationship to other quality improvement efforts, and how they may affect clinical workflow and other processes. While we will be taking notes on and recording your interview, your name will not be associated with any of these documents or files, and you will not be quoted or identified in any way in the analysis of these interviews, which will be done in the aggregate.

  1. To begin, can you tell us your role here, how long you’ve worked here, and how, if at all, your role relates to oversight of the task of infection control?

  2. Please tell us about your current involvement in quality improvement efforts, such as those focused on infection control.

  3. How does your leadership team monitor the effectiveness of changes that are implemented?

  4. What is your sense of the overall priority currently placed on infection control in your facility? Have you established specific improvement targets or benchmarks?

  5. What is the approach to quality improvement taken in this organization?

  6. Once improvements are made, how are they sustained, in your experience?

  7. What have you learned about the KPC infection control project thus far? What potential barriers do you see, if any, to implementation of the new guidelines? What barriers have you observed in other infection control initiatives? How do you think it might affect clinical work flow?

  8. What resources do you think will be necessary in order to ensure that this initiative succeeds?

  9. Are there any questions or concerns you have about it?

  10. Is there anything I haven’t asked you about that you think would be important for us to know in order to understand how this implementation of new practices might work here?









Public reporting burden for this collection of information is estimated to average 60 minutes per response, the estimated time required to complete the survey. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: AHRQ Reports Clearance Officer Attention: PRA, Paperwork Reduction Project (0935-XXXX) AHRQ, 540 Gaither Road, Room # 5036, Rockville, MD 20850.

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
Authorwilliam.carroll
File Modified0000-00-00
File Created2021-02-02

© 2024 OMB.report | Privacy Policy